Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
QDPR encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. Additionally we are shipping Quinoid Dihydropteridine Reductase Kits (14) and Quinoid Dihydropteridine Reductase Proteins (14) and many more products for this protein.
Showing 10 out of 55 products:
Human Monoclonal QDPR Primary Antibody for RNAi, ELISA - ABIN562551
Ishii, Dutta, Wark, Hwang, Han, Trapp, Pfeiffer, Bansal: Human myelin proteome and comparative analysis with mouse myelin. in Proceedings of the National Academy of Sciences of the United States of America 2009
show for the first time statistically significant up regulation of iNOS (show NOS2 Antibodies) in QDPR overexpressing astrocytes. Increased expression of iNOS (show NOS2 Antibodies) associated with astrocyte pathology seen in many neurodegenerative disorders may have implications in autoimmune neurodegenerative disorders.
Mutation of dihydropteridine reductase (QDPR) inhibited the regulation of TOR (show RORC Antibodies) serine-threonine kinases (mTOR (show FRAP1 Antibodies)), suggesting that QDPR is a positive regulator of autophagy via suppressing mTOR (show FRAP1 Antibodies) signaling.
The allele frequencies for the QDPR c.68G > A(0.3%) polymorphism is not a major cause of Parkinson's disease in the Maltese.
The mutation spectrum of the QDPR gene is different in the Chinese population. Most mutations are related to severe phenotype.
JP1 (show JPH1 Antibodies) and JP2 (show JPH2 Antibodies) can facilitate the assembly of DHPR with other proteins of the excitation-contraction coupling machinery
Report suggests that serum prolactin (show PRL Antibodies) levels can be a good biomarker for optimal dosage of hydroxylated precursors in long-term treatment monitoring for DHPR-deficient patients.
the electrostatic regulatory interaction between the SPRY2 (show SPRY2 Antibodies) F loop residues (that bind to imperatoxin A) and the ASI (show ARSI Antibodies)/basic residues of RyR1 (show RYR1 Antibodies) does not influence bi-directional DHPR-RyR1 (show RYR1 Antibodies) signaling during skeletal EC coupling
less than 30 microM H2O2 increase DHPR activities, whereas levels greater than 30 microM H2O2 deactivate the enzyme based on the oxidation of Met146 and Met151 in the sequence, consequently leading to disruption of the NADH-dependent enzyme active site.
wide alterations in folate-associated metabolism in the Qdpr(-/-) mice
voltage dependence of DHPR-triggered Ca(2 (show CA2 Antibodies)+) release flux was left-shifted by approximately 8 mV by mutation in RyR1 (show RYR1 Antibodies) (Y522S)
This gene encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Mutations in this gene resulting in QDPR deficiency include aberrant splicing, amino acid substitutions, insertions, or premature terminations. Dihydropteridine reductase deficiency presents as atypical phenylketonuria due to insufficient production of biopterin, a cofactor for phenylalanine hydroxylase.
, dihydropteridine reductase
, short chain dehydrogenase/reductase family 33C, member 1
, quinoid dihydropteridine reductase
, Dihydropteridine reductase
, quinoid dihydropteridine reductase a